FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule

Up

2003P-0365:GALDERMA PRODUCT, SOLAGE CONTAINING 2% MEQUINOL, AND 0.01% TRETINOIN, NDA 20-922 CAN BE FORMULATED AS A TOPICAL SOLUTION WITH THE SUBSTITUTION OF HYDROQUINONE AT 4% FOR THE 2% MEQUINOL AS AN ANDA
Document # Received Date Filed Date Submitter Code Submitter FR Date FR Page Comment Date Files Remarks
 
CP1 08/12/2003 08/13/2003 Private Industry Jerussi Consulting, Inc.      

pdf,
Copyrighted Material

 
Signature: Robert A. Jerussi, Ph.D.
ACK1 08/13/2003 08/13/2003 Federal Government
HFA-305 to Jerussi Consulting, Inc.       pdf, doc  
Signature: Lyle D. Jaffe
C1 11/14/2003 11/14/2003 Drug Industry Galderma Laboratories       pdf  
Signature: Paul Clark
C2 01/16/2004 01/16/2004 Private Industry Jerussi Consulting, Inc.       pdf  
Signature: Robert A. Jerussi, PhD
LET1 02/05/2004 02/05/2004 Federal Government
HFD-600 to Jerussi Consulting Inc       pdf  
Signature: Gary Buehler
LET2 03/30/2004 03/30/2004 Private Industry Jerussi Consulting, Inc.       pdf  
Signature: Robert A. Jerussi, PhD
PDN1 10/19/2004 10/19/2004 Federal Government
HFD-600 to Jerussi Consulting, Inc.       pdf  
Signature: Gary J. Buehler
LET3 11/12/2004 11/12/2004 Private Industry Jerussi Consulting, Inc.       pdf  
Signature: Robert A. Jerussi, PhD
PDN2 12/03/2004 12/03/2004 Federal Government
HFD-600 to Jerussi Consulting, Inc.       pdf  
Signature: Gary J. Buehler

Top | Up

Page last updated December 30, 2004 kk

[Skip Navigation] link to FDA home page link to U.S. Department of Health and Human Services FDA logo--link to FDA home page